Zenith Drugs Limited (NSE:ZENITHDRUG)
41.65
+0.55 (1.34%)
Jun 17, 2026, 3:27 PM IST
Zenith Drugs Market Cap
Zenith Drugs has a market cap or net worth of 714.25 million as of June 17, 2026. Its market cap has decreased by -44.54% in one year.
Market Cap
714.25M
Enterprise Value
1.26B
Revenue
1.76B
Ranking
n/a
PE Ratio
18.11
Stock Price
41.65
Market Cap Chart
Since February 27, 2024, Zenith Drugs's market cap has decreased from 1.80B to 714.25M, a decrease of -60.39%. That is a compound annual growth rate of -33.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 714.25M | -17.03% |
| Dec 31, 2025 | 860.87M | -37.87% |
| Dec 31, 2024 | 1.39B | -23.16% |
| Feb 27, 2024 | 1.80B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 9.26B |
| Remus Pharmaceuticals | 9.02B |
| Infinium Pharmachem | 3.06B |
| Quest Laboratories | 1.85B |
| Sotac Pharmaceuticals | 1.23B |
| Vilin Bio Med | 643.10M |
| Medicamen Organics | 238.10M |
| Sunrest Lifescience | 145.47M |